Browse Drug Recalls

24 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 24 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 24 FDA drug recalls.

Clear
DateProductReasonClassFirm
Aug 25, 2020 Nature Throid, 3/4 Grain (48.75 mg) Thyroid USP [Liothyronine (T3) 6.75 mcg, ... Subpotent Drug: FDA analysis found product to be subpotent Class I RLC Labs Inc.
Aug 25, 2020 Nature Throid, 2 Grain (130 mg) Thyroid USP [Liothyronine (T3) 18 mcg, Levoth... Subpotent Drug: FDA analysis found product to be subpotent Class I RLC Labs Inc.
Aug 25, 2020 WP Thyroid, Westhroid Pure, 1.5 Grain (97.5 mg) Thyroid USP packaged in a) 1,... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 Nature-Throid, Thyroid USP [liothyronine (T3) 18 mcg and levothyroxine (T4) 7... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 Nature Throid, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg, Le... Subpotent Drug: FDA analysis found product to be subpotent Class I RLC Labs Inc.
Aug 25, 2020 WP Thyroid, Westhroid Pure, 1.75 Grain (113.75 mg) Thyroid USP, packaged in a... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP packaged in a) 1,... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 Nature-Throid, Thyroid USP [liothyronine (T3) 27 mcg and levothyroxine (T4) 1... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 WP Thyroid, Westhroid Pure, Thyroid USP, [liothyronine (T3) 2.25 mcg and levo... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 Nature-Throid, Thyroid USP [liothyronine (T3) 13.5 mcg and levothyroxine (T4)... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3... Subpotent Drug: FDA analysis found product to be subpotent Class I RLC Labs Inc.
Aug 25, 2020 Nature-Throid, Thyroid USP [liothyronine (T3) 9 mcg and levothyroxine (T4) 38... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 WP Thyroid, Westhroid Pure, 1.25 Grain (81.25 mg) Thyroid USP packaged in a) ... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 Nature Throid, 1.5 Grain (97.5 mg) Thyroid USP [Liothyronine (T3) 13.5 mcg, L... Subpotent Drug: FDA analysis found product to be subpotent Class I RLC Labs Inc.
Aug 25, 2020 WP Thyroid, Westhroid Pure, 2 Grain (130 mg) Thyroid USP packaged in a) 1,000... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 WP Thyroid, Westhroid Pure, 3/4 Grain (48.75 mg) Thyroid USP, packaged in a) ... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 Nature-Throid, Thyroid USP [liothyronine (T3) 20.25 mcg and levothyroxine (T4... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 Nature Throid, 1.25 Grain (81.25 mg) Thyroid USP [Liothyronine (T3) 11.25 mcg... Subpotent Drug: FDA analysis found product to be subpotent Class I RLC Labs Inc.
Aug 25, 2020 Nature-Throid, Thyroid USP [liothyronine (T3) 22.5 mcg and levothyroxine (T4)... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 Nature-Throid, Thyroid USP [liothyronine (T3) 4.5 mcg and levothyroxine (T4) ... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 Nature-Throid, Thyroid USP [liothyronine (T3) 6.75 mcg and levothyroxine (T4)... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 Nature-Throid, Thyroid USP [liothyronine (T3) 11.25 mcg and levothyroxine (T4... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 Nature-Throid, Thyroid USP [liothyronine (T3) 15.75 mcg and levothyroxine (T4... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.
Aug 25, 2020 WP Thyroid, Westhroid Pure, 1 Grain (65 mg) Thyroid USP, packaged in a) 1,000... CGMP Deviations: manufactured under the same conditions as those found to be subpotent. Class II RLC Labs Inc.

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.